|
Isi :
Berita terkini 2014
Siaran Pers Ditujukan untuk Jurnalis, Analis, and Investor.
-
Nopember 20, 2014
Sanofi Outlines Next Wave of Innovative Medicines and Vaccines
-
Nopember 11, 2014
Sanofi and Regeneron Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma
-
Nopember 03, 2014
The New England Journal of Medicine Publishes Results of Final Landmark Phase III Efficacy Clinical Study of Sanofi Pasteur’s Dengue Vaccine Candidate
-
Oktober 29, 2014
Statement from Sanofi Board of Directors
-
Oktober 28, 2014
Sanofi delivers Business EPS(1) growth of 10.3% at CER in Q3 2014
-
September 04, 2014
Sanofi successfully prices EUR 3 billion bond issue
-
September 03, 2014
Sanofi Pasteur’s Dengue Vaccine Candidate Successfully Completes Final Landmark Phase III Clinical Efficacy Study in Latin America
-
Juli 31, 2014
Solid sales and Business EPS growth at CER in Q2 2014
-
Juli 11, 2014
First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue Fever and Dengue Haemorrhagic Fever in Asia
-
Juni 15, 2014
“Unity and Harmony: Key in the Fight Against Dengue”
-
Mei 05, 2014
Shantha’s Pentavalent Pediatric Vaccine prequalified by World Health Organization
-
April 29, 2014
Q1 2014 Business EPS(1) up 5.8% at CER
-
April 25, 2014
Sanofi Reaches New Milestone in Fight Against Malaria: 300 million ASAQ Treatments Delivered in Africa
-
Maret 19, 2014
Sanofi Pasteur Allies with SK Chemical Co. of South Korea on Pneumococcal Conjugate Vaccine
-
Februari 28, 2014
Inactivated Polio Vaccines Broadly for the World’s Children in Drive toward Polio Eradication
-
Februari 11, 2014
“India’s vast polio achievement is a call for action for all of us” says Sanofi Pasteur CEO
-
Februari 06, 2014
Sanofi Returns to Growth in Q4 2013
-
Januari 02, 2014
Sanofi To Expand Access to Clinical Trial Data
|
|